IP
COLL icon

Intellectus Partners’s Collegium Pharmaceutical COLL Stock Holding History

Intellectus Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-171
Closed -$3K – 299
2018
Q3 		$3K Buy
171
+57
+50% +$1.01K ﹤0.01% 544
2018
Q2 		$3K Buy
114
+57
+100% +$1.4K ﹤0.01% 551
2018
Q1 		$1K Buy
+57
New +$1.36K ﹤0.01% 578

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Intellectus Partners's COLL Position: Q4 2018 in Review

Intellectus Partners sold out of Collegium Pharmaceutical (COLL) in Q4 2018, closing a stake of 171 shares — an estimated $3K sold.

Intellectus Partners first reported a position in COLL in Q1 2018 and held it in 3 quarters. The position peaked at $3K in Q3 2018. 120 funds tracked by Wall St. Rank hold COLL as of Q4 2018.

  • Intellectus Partners reported no remaining Collegium Pharmaceutical position as of Q4 2018 after selling out during the quarter.
  • Intellectus Partners sold 171 Collegium Pharmaceutical shares in Q4 2018, an estimated $3K.
  • Intellectus Partners first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 3 quarters.
  • Intellectus Partners's Collegium Pharmaceutical position peaked at $3K in Q3 2018.
  • 120 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.